Literature DB >> 14596592

Structural elements required for deamidation of RhoA by cytotoxic necrotizing factor 1.

Lori Buetow1, Partho Ghosh.   

Abstract

Cytotoxic necrotizing factor 1 (CNF1), a virulence factor expressed by pathogenic Escherichia coli, acts on Rho-GTPases and specifically deamidates a single glutamine residue (Gln-63 in RhoA) required for GTP hydrolysis. This modification constitutively activates the effector binding function of Rho-GTPases and eventually leads to their proteasome-mediated degradation. Previous structural investigation revealed that the CNF1 active site is located in a deep and narrow pocket and that the entrance to this pocket is formed by nine loop segments. We have examined the functional importance of five of these loops (2, 6, 7, 8, and 9) by deleting them individually. We find that deletion of proximally located loops 8 and 9 in the 32 kDa catalytic domain of CNF1 (CNF1-C) nearly or completely abolishes deamidation of RhoA in vitro, identifying a potential Rho-GTPase recognition site. Deletion of loop 7 causes protein folding errors, and deletion of loop 6 has a small effect on deamidation. In contrast, deletion of loop 2 is found to increase deamidation 5-7-fold, implying that this loop rearranges in binding RhoA. None of the loop deletions or wild-type CNF1-C is able to deamidate RhoA containing Asn-63 instead of Gln-63, suggesting that the fit between the toxin and its target is highly precise. In addition, we show that the specificity constant (k(cat)/K(m)) of CNF1-C for RhoA is 825 +/- 3 M(-1) s(-1). This modest value is consistent with the confining size of the active site pocket acting to exclude nonspecific targets but also limiting reactivity toward intended targets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14596592     DOI: 10.1021/bi035123l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  CNF1-like deamidase domains: common Lego bricks among cancer-promoting immunomodulatory bacterial virulence factors.

Authors:  Mengfei Ho; Amel Mettouchi; Brenda A Wilson; Emmanuel Lemichez
Journal:  Pathog Dis       Date:  2018-07-01       Impact factor: 3.166

2.  Cytotoxic necrotizing factor type 1-neutralizing monoclonal antibody NG8 recognizes three amino acids in a C-terminal region of the toxin and reduces toxin binding to HEp-2 cells.

Authors:  Kerian K Grande; Karen C Meysick; Susan B Rasmussen; Alison D O'Brien
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

3.  Role of N-terminal myristylation in the structure and regulation of cAMP-dependent protein kinase.

Authors:  Adam C Bastidas; Michael S Deal; Jon M Steichen; Malik M Keshwani; Yurong Guo; Susan S Taylor
Journal:  J Mol Biol       Date:  2012-05-19       Impact factor: 5.469

Review 4.  What a difference a Dalton makes: bacterial virulence factors modulate eukaryotic host cell signaling systems via deamidation.

Authors:  Erica J Washington; Mark J Banfield; Jeffery L Dangl
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 5.  Cytotoxic Necrotizing Factors (CNFs)-A Growing Toxin Family.

Authors:  Zeynep Knust; Gudula Schmidt
Journal:  Toxins (Basel)       Date:  2011-04-08       Impact factor: 4.546

Review 6.  The Cytotoxic Necrotizing Factors (CNFs)-A Family of Rho GTPase-Activating Bacterial Exotoxins.

Authors:  Paweena Chaoprasid; Petra Dersch
Journal:  Toxins (Basel)       Date:  2021-12-15       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.